OneFund LLC’s Gilead Sciences GILD Stock Holding History

OneFund LLC’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$478K	Sell	3,410 -142	-4%	-$19.9K	0.31%	59
2025 Q4	$436K	Buy	3,552 +201	+6%	+$24.4K	0.26%	73
2025 Q3	$372K	Buy	3,351 +122	+4%	+$13.9K	0.24%	81
2025 Q2	$358K	Sell	3,229 -23	-0.7%	-$2.45K	0.26%	74
2025 Q1	$364K	Sell	3,252 -43	-1%	-$4.44K	0.37%	69
2024 Q4	$304K	Buy	3,295 +27	+0.8%	+$2.43K	0.29%	82
2024 Q3	$274K	Buy	3,268 +13	+0.4%	+$992	0.28%	96
2024 Q2	$223K	Buy	3,255 +48	+1%	+$3.2K	0.24%	106
2024 Q1	$234K	Sell	3,207 -87	-3%	-$6.69K	0.28%	102
2023 Q4	$267K	Buy	+3,294	New	+$256K	0.35%	86

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

OneFund LLC's GILD Position: Q1 2026 in Review

OneFund LLC reduced its Gilead Sciences (GILD) stake by 4% in Q1 2026, selling an estimated $19.9K and leaving 3,410 shares worth $478K. The position accounts for 0.31% of the portfolio, ranked #59.

OneFund LLC first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

OneFund LLC held 3,410 shares of Gilead Sciences worth $478K as of Q1 2026.
OneFund LLC sold 142 Gilead Sciences shares in Q1 2026, an estimated $19.9K.
Gilead Sciences made up 0.31% of OneFund LLC's portfolio in Q1 2026, its #59 holding.
OneFund LLC first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on OneFund LLC's 13F filing for Q1 2026, filed 8 May 2026.